Open Access Databases and Datasets for Drug Discovery
Timely resource discussing the future of data-driven drug discovery and the growing number of open-source databases
With an overview of 90 freely accessible databases and datasets on all aspects of drug design, development, and discovery, Open Access Databases and Datasets for Drug Discovery is a comprehensive guide to the vast amount of “free data” available to today’s pharmaceutical researchers. The applicability of open-source data for drug discovery and development is analyzed, and their usefulness in comparison with commercially available tools is evaluated.
The most relevant databases for small molecules, drugs and druglike substances, ligand design, protein 3D structures (both experimental and calculated), and human drug targets are described in depth, including practical examples of how to access and work with the data. The first part is focused on databases for small molecules, followed by databases for macromolecular targets and diseases. The final part shows how to integrate various open-source tools into the academic and industrial drug discovery and development process.
Contributed to and edited by experts with long-time experience in the field, Open Access Databases and Datasets for Drug Discovery includes information on:
Unmatched in scope and thoroughly reviewing small and large open data sources relevant for rational drug design, Open Access Databases and Datasets for Drug Discovery is an essential reference for medicinal and pharmaceutical chemists, and any scientists involved in the drug discovery and drug development.
"synopsis" may belong to another edition of this title.
Antoine Daina is a Senior Scientist at the Molecular Modelling Group of the SIB Swiss Institute of Bioinformatics in charge of methodological developments in the SwissDrugDesign program.
Michael Przewosny has over 20 years of experience in pharmaceutical research and drug discovery, having worked as laboratory manager for different pharmaceutical companies.
Vincent Zoete is a Group Leader at the Molecular Modelling Group of the SIB Swiss Institute of Bioinformatics and an Associate Professor at the University of Lausanne, Department of Oncology UNIL-CHUV, Ludwig Institute for Cancer Research.
Timely resource discussing the future of data-driven drug discovery and the growing number of open-source databases
With an overview of 90 freely accessible databases and datasets on all aspects of drug design, development, and discovery, Open Access Databases and Datasets for Drug Discovery is a comprehensive guide to the vast amount of “free data” available to today’s pharmaceutical researchers. The applicability of open-source data for drug discovery and development is analyzed, and their usefulness in comparison with commercially available tools is evaluated.
The most relevant databases for small molecules, drugs and druglike substances, ligand design, protein 3D structures (both experimental and calculated), and human drug targets are described in depth, including practical examples of how to access and work with the data. The first part is focused on databases for small molecules, followed by databases for macromolecular targets and diseases. The final part shows how to integrate various open-source tools into the academic and industrial drug discovery and development process.
Contributed to and edited by experts with long-time experience in the field, Open Access Databases and Datasets for Drug Discovery includes information on:
Unmatched in scope and thoroughly reviewing small and large open data sources relevant for rational drug design, Open Access Databases and Datasets for Drug Discovery is an essential reference for medicinal and pharmaceutical chemists, and any scientists involved in the drug discovery and drug development.
"About this title" may belong to another edition of this title.
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # DB-9783527348398
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 41314255-n
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 41314255
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 41314255-n
Quantity: 1 available
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New. Seller Inventory # 6666-KNV-9783527348398
Quantity: 3 available
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New. Seller Inventory # 6666-LBR-9783527348398
Quantity: 1 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 41314255
Quantity: 1 available
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Antoine Daina studied Pharmacy at the University of Lausanne (Switzerland) and got a Ph.D. in Pharmaceutical Sciences from the University of Geneva. After industrial practice as computational chemist for agrochemical research and academic experience as lect. Seller Inventory # 597852059
Quantity: 1 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. Neuware -A comprehensive review of small and large open data sources relevant for rational drug design, covering small molecules, drug targets, ligand design, and many more drug-related aspects. 323 pp. Englisch. Seller Inventory # 9783527348398
Quantity: 1 available
Seller: Rheinberg-Buch Andreas Meier eK, Bergisch Gladbach, Germany
Buch. Condition: Neu. Neuware -A comprehensive review of small and large open data sources relevant for rational drug design, covering small molecules, drug targets, ligand design, and many more drug-related aspects. 323 pp. Englisch. Seller Inventory # 9783527348398
Quantity: 1 available